{"nct_id":"NCT05714202","title":"A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2023-03-23","start_date_type":"ACTUAL","primary_completion_date":"2029-09-18","primary_completion_date_type":"ESTIMATED","completion_date":"2029-09-18","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["JNJ"]}